Menu Item

Case study

Bristol Myers Squibb

Project Overviews

BLS & Co. served as site selection and incentives consultant for Bristol Myers Squibb’s new $2.3B multi-modal manufacturing facility in Houston, Texas. The project continued BLS & Co.'s decades-long relationship with BMS that has also involved substantial office and manufacturing projects in Florida and Massachusetts.

  • Texas – Multi-Modal Manufacturing: In 2026, BLS & Co. served as advisor on a comprehensive U.S. site selection process for a major advanced therapeutics manufacturing investment. The process managed a nationwide location evaluation that included site identification, labor market and workforce assessments, utility and infrastructure due diligence, executive site visits, and incentive strategy development across multiple finalist states. BLS coordinated closely with BMS leadership, developers, utility providers, and EDOs to support accelerated decision-making and implementation schedules. The project ultimately announced a capital investment of over $2.3 billion at a new site in Houston, Texas, which is expected to create 489 new jobs.
  • Florida - BLS & Co. served as site selection and incentives consultant for Bristol Myers Squibb’s new North American Capability Center (NACC) in Tampa, Florida. BMS’ goal for the NACC was to house key enterprise services, including technology, finance and accounting, alongside research and analytics in a cost-effective market. The NACC project required BLS & Co. to identify and evaluate cost-effective, high-quality markets with diverse pools of talent. BLS & Co. managed a team of brokers, designers and the company’s human resources, technology and functional leaders during an engagement that resulted in the successful site selection, incentive agreement, staffing and opening of the NACC, all within a nine-month window.
  • Massachusetts - Our firm also served as site selection and incentives consultant during a complex and highly competitive nationwide search for a new $750 million, large-scale, multi-product bulk biologics facility in Devens, Massachusetts. The Devens site, the largest capital investment in BMS history at the time, has expanded multiple times since its original announcement and now totals over $1 billion in capital investment to date.

Results

  • Over $3.3 billion in announced investment
  • More than 1,500 jobs

Energy Services